ABCL-161 Reasons for Non-Referral for Autologous Stem Cell Transplantation in Central Nervous System Lymphoma (CNSL) Patients in a Minority-Rich, Multiracial, and Underprivileged Population at Montefiore Medical Center, Albert Einstein College of Medicine

MLA

Hiba Narvel, et al. “ABCL-161 Reasons for Non-Referral for Autologous Stem Cell Transplantation in Central Nervous System Lymphoma (CNSL) Patients in a Minority-Rich, Multiracial, and Underprivileged Population at Montefiore Medical Center, Albert Einstein College of Medicine.” Clinical Lymphoma Myeloma and Leukemia, vol. 22, Oct. 2022, p. S362. EBSCOhost, https://doi.org/10.1016/s2152-2650(22)01505-1.

APA

Hiba Narvel, Shreyas Yakkali, Abdul-hamid Bazarbachi, Shuai Wang, Alyssa de Castro, Adnan Narvel, Jennat Mustafa, Fariha Khatun, Amanda Lombardo, Kira Gritsman, Mendel Goldfinger, Noah Kornblum, Aditi Shastri, Katharine Mcneill, Murali Janakiram, Ioannis Mantzaris, Amit Verma, Ira Braunschweig, & R. Alejandro Sica. (2022). ABCL-161 Reasons for Non-Referral for Autologous Stem Cell Transplantation in Central Nervous System Lymphoma (CNSL) Patients in a Minority-Rich, Multiracial, and Underprivileged Population at Montefiore Medical Center, Albert Einstein College of Medicine. Clinical Lymphoma Myeloma and Leukemia, 22, S362. https://doi.org/10.1016/s2152-2650(22)01505-1

Chicago

Hiba Narvel, Shreyas Yakkali, Abdul-hamid Bazarbachi, Shuai Wang, Alyssa de Castro, Adnan Narvel, Jennat Mustafa, et al. 2022. “ABCL-161 Reasons for Non-Referral for Autologous Stem Cell Transplantation in Central Nervous System Lymphoma (CNSL) Patients in a Minority-Rich, Multiracial, and Underprivileged Population at Montefiore Medical Center, Albert Einstein College of Medicine.” Clinical Lymphoma Myeloma and Leukemia 22 (October): S362. doi:10.1016/s2152-2650(22)01505-1.